- Home
- XERS vs AIN Comparison
XERS vs AIN Comparison
Compare XERS & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | AIN |
|---|---|---|
| Founded | 2005 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2018 | 1987 |
Fundamental Metrics
Financial Performance| Metric | XERS | AIN |
|---|---|---|
| Price | $7.32 | $50.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $10.43 | ★ $64.25 |
| AVG Volume (30 Days) | ★ 2.0M | 384.8K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $266,137,000.00 | ★ $1,148,512,000.00 |
| Revenue This Year | $44.37 | N/A |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | N/A |
| 52 Week Low | $3.14 | $41.15 |
| 52 Week High | $10.08 | $83.65 |
Technical Indicators
Market Signals| Indicator | XERS | AIN |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 53.35 |
| Support Level | $6.95 | $49.70 |
| Resistance Level | $7.26 | $51.50 |
| Average True Range (ATR) | 0.32 | 1.52 |
| MACD | 0.10 | 0.39 |
| Stochastic Oscillator | 86.67 | 55.64 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.